Key facts
- This page summarizes Leanne G. Caret's Form 4 filing for BOEING CO (BA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Feb 2022, 20:15.
Leanne G. Caret - 16 Feb 2022 Form 4 Insider Report for BOEING CO (BA)
- Reporting relationship
- EVP, Pres. & CEO, BDS
- Issuer ticker
- BA
- Reported as of
- 16 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Feb 2022, 20:15:06 UTC
- Prior SEC filing
- 03 Nov 2021
- Next SEC filing
- 01 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dana Kumar, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Leanne G. Caret filed Form 4 for BOEING CO (BA) on 18 Feb 2022.
Change
- Previous filing in this sequence was filed on 03 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +10,921
- Change %
- +16%
- Price
- $0.000000
- Shares after
- 78,570
- Date
- 16 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
BA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 99
- Date
- 16 Feb 2022
- Ownership
- By Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BA
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +28,600
- Change %
- Price
- $0.000000
- Shares after
- 28,600
- Date
- 16 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 28,600
- Exercise price
- $260.98
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents restricted stock units that will vest and settle in shares of the Company's common stock on a one-for-one basis on February 17, 2025.
Footnote F2
The exercise price is equal to 120% of the average of the high and the low trading prices on the date of the grant (the "Grant Date FMV"). The exercise price will be reduced to 110% of the Grant Date FMV if the issuer's total shareholder return ("TSR") over the three-year vesting period exceeds the median TSR for the peer group of companies listed in the award agreement.
Footnote F3
The option becomes vested and exercisable in full on February 16, 2025, which is the third anniversary of the date of grant.